KALV R&D Expense Growth
Kalvista Pharmaceuticals Inc · R&D Expense Growth
KALV R&D Expense Growth
Latest reported-22.41%period ending
KALV FY R&D Growth (YoY) (0.00% → -22.41%)
Latest values, visible window
High-resolution chart · PNG
KALV r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -22.4093% | |
| -16.779% | |
| 7.3384% | |
| 14.4071% | |
| 69.9535% | |
| 2.7168% | |
| 14.7711% | |
| 92.0327% | |
| 43.9839% | |
| -13.6075% | |
| 76.9584% | |
| 95.9092% | |
| 115.8754% | |
| 0% |